Location History:
- Foster City, CA (US) (2023)
- Kirkland, WA (US) (2024)
Company Filing History:
Years Active: 2023-2025
Title: The Innovative Contributions of Stephen D Holmbo
Introduction
Stephen D Holmbo is a notable inventor based in Kirkland, WA (US). He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of 4 patents to his name, Holmbo's work has the potential to impact the medical community profoundly.
Latest Patents
Holmbo's latest patents include innovative compounds aimed at treating cancer. One of his notable inventions is related to PARP7 inhibitors, which provides a compound of Formula I or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers, or deuterated analog thereof. This invention also includes a pharmaceutical composition comprising the compound, along with a method of treating cancer. Another significant patent involves diacylglycerol kinase modulating compounds, which are designed for treating cancer, including solid tumors, and viral infections such as HIV or hepatitis B virus infection. These compounds can be utilized alone or in combination with other agents, showcasing their versatility in therapeutic applications.
Career Highlights
Throughout his career, Holmbo has worked with prominent companies in the pharmaceutical industry. He has been associated with Gilead Sciences, Inc. and Carna Biosciences, Inc., where he has contributed to various research and development projects. His work in these organizations has further solidified his reputation as an innovative inventor in the field.
Collaborations
Holmbo has collaborated with several professionals in his field, including Heath A Weaver and Juan A Guerrero. These collaborations have likely enhanced his research and contributed to the successful development of his patented inventions.
Conclusion
Stephen D Holmbo's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight his role as a significant inventor. His patents reflect a commitment to advancing medical science and improving patient outcomes. His work continues to inspire future innovations in the field.